Focal Müllerian duct retention in male mice with constitutively activated β-catenin expression in the Müllerian duct mesenchyme

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 37, 2010, Pages 16142-16147

  Tanwar, Pradeep S ^a   Zhang, LiHua ^a   Tanaka, Yoshihiro ^a   Taketo, Makoto M ^c   Donahoe, Patricia K ^b   Teixeira, Jose M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Anti M llerian hormone; Epididymis; Mullerian inhibiting substance type II receptor (MISRII or MISR2); Spermatocele

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BIOLOGICAL MARKER; DESMIN; MUELLERIAN INHIBITING FACTOR; PROTEIN AMHR2; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG; WNT7A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AZOOSPERMIA; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; EPIDIDYMIS; FEMALE; GROWTH INHIBITION; IN SITU HYBRIDIZATION; MALE; MALE INFERTILITY; MESENCHYME; MOUSE; MUELLERIAN DUCT; MUTANT; NONHUMAN; NUCLEAR IMPORT; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINIFEROUS TUBULE; SIGNAL TRANSDUCTION; SPERMATOCELE; SPERMATOGENESIS; TESTIS; TISSUE DIFFERENTIATION; TISSUE STRUCTURE; UROGENITAL SINUS; UTERUS; VAS DEFERENS; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; MESODERM; METABOLISM; TISSUE CULTURE TECHNIQUE;

MUS;

ANIMALS; BETA CATENIN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MESODERM; MICE; MULLERIAN DUCTS; TISSUE CULTURE TECHNIQUES;

EID: 77958009978     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1011606107     Document Type: Article

References (46)

1. Teixeira J, Maheswaran S, Donahoe PK (2001) Müllerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 22:657-674. (Pubitemid 32955249)
2. Josso N, Picard JY, Rey R, di Clemente N (2006) Testicular anti-Müllerian hormone: History, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 3:347-358.
3. Behringer RR, Finegold MJ, Cate RL (1994) Müllerian-inhibiting substance function during mammalian sexual development. Cell 79:415-425. (Pubitemid 24346057)
4. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR (2002) Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat Genet 32:408-410. (Pubitemid 35266116)
5. Clarke TR, et al. (2001) Mullerian inhibiting substance signaling uses a BMP-like pathway mediated by ALK2 and induces Smad6 expression. Mol Endocrinol 15:946-959.
6. Visser JA, et al. (2001) The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. Mol Endocrinol 15:936-945.
7. Mishina Y, et al. (1996) Genetic analysis of the Müllerian- inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10:2577-2587.
8. Josso N, Belville C, di Clemente N, Picard JY (2005) AMH and AMH receptor defects in persistent Müllerian duct syndrome. Hum Reprod Update 11:351-356.
9. Miller C, Sassoon DA (1998) Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125:3201-3211. (Pubitemid 28434418)
10. Parr BA, McMahon AP (1998) Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 395:707-710.
11. Mericskay M, Kitajewski J, Sassoon D (2004) Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 131:2061-2072.
12. Mikels AJ, Nusse R (2006) Wnts as ligands: Processing, secretion and reception. Oncogene 25:7461-7468.
13. Nusse R (2008) Wnt signaling and stem cell control. Cell Res 18:523-527.
14. Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88.
15. Allard S, et al. (2000) Molecular mechanisms of hormone-mediated Müllerian duct regression: Involvement of beta-catenin. Development 127:3349-3360. (Pubitemid 30649545)
16. Harada N, et al. (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18:5931-5942. (Pubitemid 29515670)
17. Tanwar PS, et al. (2009) Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice. Biol Reprod 81:545-552.
18. Tanwar PS, et al. (2010) Constitutive WNT/beta-catenin signaling in murine Sertoli cells disrupts their differentiation and ability to support spermatogenesis. Biol Reprod 82:422-432.
19. Boyer A, Hermo L, Paquet M, Robaire B, Boerboom D (2008) Seminiferous tubule degeneration and infertility in mice with sustained activation of WNT/CTNNB1 signaling in sertoli cells. Biol Reprod 79:475-485.
20. Chang H, et al. (2008) Wt1 negatively regulates beta-catenin signaling during testis development. Development 135:1875-1885.
21. Kobayashi A, Behringer RR (2003) Developmental genetics of the female reproductive tract in mammals. Nat Rev Genet 4:969-980.
22. Joseph A, Yao H, Hinton BT (2009) Development and morphogenesis of the Wolffian/epididymal duct, more twists and turns. Dev Biol 325:6-14.
23. Archambeault DR, Tomaszewski J, Joseph A, Hinton BT, Yao HH (2009) Epithelial-mesenchymal crosstalk in Wolffian duct and fetal testis cord development. Genesis 47:40-48.
24. Shtutman M, et al. (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522-5527.
25. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
26. Roose J, et al. (1999) Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285:1923-1926. (Pubitemid 129515516)
27. Hovanes K, et al. (2001) Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28:53-57.
28. Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF (2002) Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter. J Biol Chem 277:33398-33410.
29. Zhan Y, et al. (2006) Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression. Development 133:2359-2369. (Pubitemid 44044557)
30. Eivers E, Fuentealba LC, De Robertis EM (2008) Integrating positional information at the level of Smad1/5/8. Curr Opin Genet Dev 18:304-310.
31. Fuentealba LC, et al. (2007) Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131:980-993.
32. Josso N, Picard JY, Tran D (1977) The anti-Müllerian hormone. Birth Defects Orig Artic Ser 13:59-84.
33. Donahoe PK, Ito Y, Hendren WH, 3rd (1977) A graded organ culture assay for the detection of Mullerian inhibiting substance. J Surg Res 23:141-148.
34. Picon R (1969) Action of the fetal testis on the development in vitro of the Müllerian ducts in the rat. Arch Anat Microsc Morphol Exp 58:1-19.
35. Arango NA, et al. (2008) A mesenchymal perspective of Müllerian duct differentiation and regression in Amhr2-lacZ mice. Mol Reprod Dev 75:1154-1162.
36. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469-480.
37. Donahoe PK, Crawford JD, Hendren WH (1977) Management of neonates and children with male pseudohermaphroditism. J Pediatr Surg 12:1045-1057.
38. Donahoe PK (1988) Neoseminal vesicle created from retained mullerian duct to preserve the vas in male infants. J Pediatr Surg 23:272-274.
39. Thiel DD, Erhard MJ (2005) Uterine adenosarcoma in a boy with persistent müllerian duct syndrome: First reported case. J Pediatr Surg 40:e29-e31.
40. Shinmura Y, Yokoi T, Tsutsui Y (2002) A case of clear cell adenocarcinoma of the müllerian duct in persistent müllerian duct syndrome: The first reported case. Am J Surg Pathol 26:1231-1234. (Pubitemid 34969193)
41. Rubenstein RA, Dogra VS, Seftel AD, Resnick MI (2004) Benign intrascrotal lesions. J Urol 171:1765-1772.
42. Hirsh AV, Dean NL, Mohan PJ, Shaker AG, Bekir JS (1996) Natural spermatoceles in irreversible obstructive azoospermia - reservoirs of viable spermatozoa for assisted conception. Hum Reprod 11:1919-1922.
43. Srinivas S, et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:4.
44. Lorenzo HK, et al. (2002) New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity. J Chromatogr B Analyt Technol Biomed Life Sci 766:89-98.
45. Arango NA, et al. (2005) Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 288:276-283.
46. Teixeira J, et al. (1996) Developmental expression of a candidate müllerian inhibiting substance type II receptor. Endocrinology 137:160-165. (Pubitemid 26004987)